Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$553,308
-$511,835 QoQ
Shares Held
4,200
-44.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Sep 30, 2024CallValue
$1,325,030
CallShares
11,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NOMURA HOLDINGS INC holds $237,265,146 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
604,264 | $71,430,047 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,338,602 | $70,438,692 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
8,986,372 | $48,526,408 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
237,225 | $18,242,602 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
342,939 | $16,512,512 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
18,984 | $11,257,132 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
4,200 | $553,308 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
14,665 | $304,445 |
All Filings in NBIX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $553,308 | 4,200 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,065,143 | 7,510 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,284,617 | 9,151 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $1,833,741 | 13,434 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,325,030 | 11,500 | Call | Defined | 2025-01-13 | |
| 2024-06-30 | $2,312,856 | 16,800 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $234,039 | 1,700 | Shares | Defined | 2024-08-14 | |
| 2022-09-30 | $955,890 | 9,000 | Shares | Defined | 2022-11-15 | |
| 2022-09-30 | $4,768,829 | 44,900 | Call | Defined | 2022-11-15 | |
| 2022-06-30 | $8,734,208 | 89,600 | Call | Sole | 2022-08-17 | |
| 2022-03-31 | $5,981,250 | 63,800 | Call | Sole | 2022-05-18 | |
| 2021-12-31 | $383,265 | 4,500 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $1,167,000 | 12,000 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $3,654,080 | 38,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,760,000 | 80,000 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $759,130 | 8,771 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||